• Wellgistics Health entered a binding term sheet with Datavault AI to build a new healthcare platform branded DelivMeds AI through three concurrent transactions.
• The deal expands Datavault AI’s PharmacyChain license to cover Healthcare-as-a-Service intellectual property, pairing it with Wellgistics’ EinsteinRx dispensing-optimization AI and its pharmacy network of more than 6,500 pharmacies.
• DelivMeds AI would also acquire the QOLPOM biometric health data and drone logistics intellectual property from EOS Technology Holdings and Scilex, targeting wearables-based identity and drug-effect confirmation for home delivery.
• A controlling stake in Tollo Health is also slated to be acquired, adding telemedicine, AI-enabled coaching, and medical foods and supplements aimed at GLP-1 muscle loss and viral-infection indications.
• The three transactions imply an expected combined asset value of about $4 billion, subject to an independent fairness opinion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Datavault Ai Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260520800818) on May 20, 2026, and is solely responsible for the information contained therein.